Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

TL;DR

This paper corrects a previous study on new compounds that may help in breast cancer treatment by affecting cell death and enzymes.

Contribution

The paper provides a correction to prior research on multifunctional hybrids for breast cancer therapy.

Findings

The original study focused on the synthesis and testing of new compounds.

These compounds were shown to influence apoptosis and topoisomerase II.

In vitro and in silico methods were used to evaluate their potential.

Abstract

Correction for ‘New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies’ by Heba W. Alhamdi et al., RSC Adv., 2024, 14, 28555–28568, https://doi.org/10.1039/D4RA04219K.